Michael S. Ostrach
Keine laufenden Positionen mehr
Profil
Michael S.
Ostrach served as President & Chief Operating Officer at Kosan Biosciences, Inc. from 1997 to 2004.
He was the SVP-Corporate Affairs & General Counsel at Cetus Corp.
from 1981 to 1991.
Ostrach also served as Chief Operating & Financial Officer at Threshold Pharmaceuticals, Inc. in 2005 and Senior VP, Chief Financial & Business Officer at Dynavax Technologies Corp.
from 2016 to 2021.
He was also the President of Chiron Technologies, Inc. Ostrach received his undergraduate degree from Brown University in 1973 and his graduate degree from Stanford Law School in 1976.
Ehemalige bekannte Positionen von Michael S. Ostrach
| Unternehmen | Position | Ende |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Director of Finance/CFO | 01.03.2021 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Director of Finance/CFO | 27.10.2006 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | President | 01.01.2004 |
| Cetus Corp. | General Counsel | 01.01.1991 |
Chiron Technologies, Inc.
 Chiron Technologies, Inc. Computer Processing HardwareElectronic Technology Chiron Technologies, Inc. focuses on electronic computers. The company is headquartered in Colts Neck, NJ. | President | - |
Ausbildung von Michael S. Ostrach
| Brown University | Undergraduate Degree |
| Stanford Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
| Cetus Corp. | Health Technology |
Chiron Technologies, Inc.
Chiron Technologies, Inc. Computer Processing HardwareElectronic Technology Chiron Technologies, Inc. focuses on electronic computers. The company is headquartered in Colts Neck, NJ. | Electronic Technology |
